Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Poseida Therapeutics, Inc. (PSTX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Poseida Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1661460.
Total stock buying since 2020: $15,917,227.
Total stock sales since 2020: $6,846,577.
Total stock option exercises since 2020: $1,797,602.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 60,000 | $561,960 | 60,000 | $166,860 |
| 2022 | 2,295,857 | $8,036,939 | 160,696 | $592,807 | 0 | $0 |
| 2021 | 499,548 | $3,560,288 | 604,454 | $5,691,810 | 414,813 | $1,630,742 |
| 2020 | 270,000 | $4,320,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 0 | $0 | 30,000 | $283,860 | 30,000 | $83,430 |
| 2024-11 | 0 | $0 | 30,000 | $278,100 | 30,000 | $83,430 |
| 2022-08 | 2,292,857 | $8,024,999 | 160,696 | $592,807 | 0 | $0 |
| 2022-03 | 3,000 | $11,940 | 0 | $0 | 0 | $0 |
| 2021-12 | 24,489 | $167,965 | 0 | $0 | 15,716 | $22,096 |
| 2021-11 | 475,059 | $3,392,323 | 18,924 | $134,171 | 1,000 | $9,150 |
| 2021-10 | 0 | $0 | 20,029 | $140,603 | 18,525 | $169,503 |
| 2021-09 | 0 | $0 | 152,411 | $1,266,384 | 31,281 | $123,072 |
| 2021-08 | 0 | $0 | 37,673 | $306,109 | 115,149 | $1,022,301 |
| 2021-07 | 0 | $0 | 48,105 | $456,352 | 20,000 | $26,440 |
| 2021-06 | 0 | $0 | 4,000 | $37,748 | 9,000 | $11,898 |
| 2021-05 | 0 | $0 | 54,312 | $468,838 | 0 | $0 |
| 2021-04 | 0 | $0 | 4,000 | $33,752 | 9,000 | $11,898 |
| 2021-03 | 0 | $0 | 115,000 | $1,347,321 | 0 | $0 |
| 2021-02 | 0 | $0 | 145,538 | $1,455,912 | 178,929 | $217,784 |
| 2021-01 | 0 | $0 | 4,462 | $44,620 | 16,213 | $16,600 |
| 2020-07 | 270,000 | $4,320,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-10 | Gergen Mark J (Executive Chairman) | Sale | 30,000 | 9.46 | 283,860 |
| 2024-12-10 | Gergen Mark J (Executive Chairman) | Option Ex | 30,000 | 2.78 | 83,430 |
| 2024-11-26 | Gergen Mark J (Executive Chairman) | Sale | 30,000 | 9.27 | 278,100 |
| 2024-11-26 | Gergen Mark J (Executive Chairman) | Option Ex | 30,000 | 2.78 | 83,430 |
| 2022-08-08 | Ostertag Eric (Executive Chairman) | Buy | 142,857 | 3.50 | 499,999 |
| 2022-08-08 | Malin Life Sciences Holdings Ltd | Buy | 2,150,000 | 3.50 | 7,525,000 |
| 2022-08-03 | Ostertag Eric (Executive Chairman) | Sale | 160,696 | 3.69 | 592,807 |
| 2022-03-16 | Ingalls Kerry D. (Chief Operating Officer) | Buy | 3,000 | 3.98 | 11,940 |
| 2021-12-21 | Mylet Johanna (Chief Financial Officer) | Option Ex | 5,716 | 1.55 | 8,876 |
| 2021-12-06 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 10,000 | 1.32 | 13,220 |
| 2021-12-06 | Malin Life Sciences Holdings Ltd | Buy | 1,828 | 6.90 | 12,613 |
| 2021-12-02 | Malin Life Sciences Holdings Ltd | Buy | 4,296 | 6.88 | 29,552 |
| 2021-12-01 | Malin Life Sciences Holdings Ltd | Buy | 18,365 | 6.85 | 125,800 |
| 2021-11-30 | Malin Life Sciences Holdings Ltd | Buy | 28,592 | 6.85 | 195,826 |
| 2021-11-29 | Malin Life Sciences Holdings Ltd | Buy | 11,057 | 6.89 | 76,204 |
| 2021-11-26 | Malin Life Sciences Holdings Ltd | Buy | 27,251 | 6.81 | 185,497 |
| 2021-11-24 | Malin Life Sciences Holdings Ltd | Buy | 1,054 | 6.89 | 7,259 |
| 2021-11-23 | Malin Life Sciences Holdings Ltd | Buy | 14,625 | 6.77 | 98,996 |
| 2021-11-19 | Ostertag Eric (Chief Executive Officer) | Option Ex | 1,000 | 9.15 | 9,150 |
| 2021-11-19 | Malin Life Sciences Holdings Ltd | Buy | 11,104 | 7.44 | 82,647 |
| 2021-11-18 | Malin Life Sciences Holdings Ltd | Buy | 71,312 | 7.17 | 511,663 |
| 2021-11-17 | Ingalls Kerry D. (Chief Operating Officer) | Buy | 2,000 | 7.00 | 14,000 |
| 2021-11-17 | Malin Life Sciences Holdings Ltd | Buy | 280,384 | 7.21 | 2,021,849 |
| 2021-11-16 | Malin Life Sciences Holdings Ltd | Buy | 27,680 | 7.17 | 198,382 |
| 2021-11-08 | Ostertag Eric (Chief Executive Officer) | Sale | 18,924 | 7.09 | 134,171 |
| 2021-10-11 | Ostertag Eric (Chief Executive Officer) | Option Ex | 18,525 | 9.15 | 169,503 |
| 2021-10-01 | Ostertag Eric (Chief Executive Officer) | Sale | 20,029 | 7.02 | 140,603 |
| 2021-09-20 | Ostertag Eric (Chief Executive Officer) | Sale | 20,000 | 8.00 | 160,020 |
| 2021-09-14 | Ostertag Eric (Chief Executive Officer) | Sale | 20,000 | 8.14 | 162,719 |
| 2021-09-13 | Ostertag Eric (Chief Executive Officer) | Option Ex | 21,281 | 5.16 | 109,852 |
| 2021-09-09 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 10,000 | 1.32 | 13,220 |
| 2021-09-02 | Ostertag Eric (Chief Executive Officer) | Sale | 61,262 | 8.34 | 510,925 |
| 2021-09-01 | Ostertag Eric (Chief Executive Officer) | Sale | 51,149 | 8.46 | 432,720 |
| 2021-08-20 | Spear Matthew A. (Chief Medical Officer) | Sale | 4,000 | 8.79 | 35,140 |
| 2021-08-20 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 4,000 | 1.32 | 5,288 |
| 2021-08-06 | Ostertag Eric (Chief Executive Officer) | Option Ex | 111,149 | 9.15 | 1,017,013 |
| 2021-08-03 | Ostertag Eric (Chief Executive Officer) | Sale | 19,936 | 7.99 | 159,288 |
| 2021-08-02 | Ostertag Eric (Chief Executive Officer) | Sale | 13,737 | 8.13 | 111,681 |
| 2021-07-28 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 20,000 | 1.32 | 26,440 |
| 2021-07-02 | Ostertag Eric (Chief Executive Officer) | Sale | 27,542 | 9.28 | 255,452 |
| 2021-07-01 | Ostertag Eric (Chief Executive Officer) | Sale | 20,563 | 9.77 | 200,900 |
| 2021-06-17 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 5,000 | 1.32 | 6,610 |
| 2021-06-11 | Spear Matthew A. (Chief Medical Officer) | Sale | 4,000 | 9.44 | 37,748 |
| 2021-06-11 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 4,000 | 1.32 | 5,288 |
| 2021-05-04 | Ostertag Eric (Chief Executive Officer) | Sale | 35,986 | 8.44 | 303,721 |
| 2021-05-03 | Ostertag Eric (Chief Executive Officer) | Sale | 18,326 | 9.01 | 165,117 |
| 2021-04-23 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 5,000 | 1.32 | 6,610 |
| 2021-04-21 | Spear Matthew A. (Chief Medical Officer) | Sale | 4,000 | 8.44 | 33,752 |
| 2021-04-21 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 4,000 | 1.32 | 5,288 |
| 2021-03-02 | Ostertag Eric (Chief Executive Officer) | Sale | 57,060 | 11.54 | 658,415 |
| 2021-03-01 | Ostertag Eric (Chief Executive Officer) | Sale | 57,940 | 11.89 | 688,906 |
| 2021-02-23 | Ostertag Eric (Chief Executive Officer) | Option Ex | 111,395 | 1.17 | 130,666 |
| 2021-02-16 | Ostertag Eric (Chief Executive Officer) | Sale | 133,149 | 10.00 | 1,332,022 |
| 2021-02-10 | Ostertag Eric (Chief Executive Officer) | Sale | 12,389 | 10.00 | 123,890 |
| 2021-02-10 | Ostertag Eric (Chief Executive Officer) | Option Ex | 67,534 | 1.29 | 87,118 |
| 2021-01-21 | Ostertag Eric (Chief Executive Officer) | Sale | 4,462 | 10.00 | 44,620 |
| 2021-01-15 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 7,564 | 1.32 | 9,999 |
| 2021-01-15 | Mylet Johanna (Senior Vice President, Finance) | Option Ex | 4,728 | .30 | 1,418 |
| 2021-01-08 | Spear Matthew A. (Chief Medical Officer) | Option Ex | 3,921 | 1.32 | 5,183 |
| 2020-07-14 | Murphy Sean (Director) | Buy | 10,000 | 16.00 | 160,000 |
| 2020-07-14 | Hirsch David (Director) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-07-14 | Lloyd Marcea Bland (Director) | Buy | 10,000 | 16.00 | 160,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of PSTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Poseida Therapeutics, Inc. (symbol PSTX, CIK number 1661460) see the Securities and Exchange Commission (SEC) website.